Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
135.4 USD | -0.91% | -2.86% | +2.77% |
May. 31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
May. 28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 143.74 | 143.74 | 142.29 |
Spread/Res. | -5.80% | -5.80% | -4.84% |
Spread/Supp. | +3.84% | +3.84% | +15.82% |
Support | 130.40 | 130.40 | 116.91 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NBIX Stock
- Charts Neurocrine Biosciences, Inc.